SCHEMBL6402407

SCHEMBL6402407

N#C[C@@H](C(=O)O)C(c1ccccc1C(F)(F)F)c1cccc2ccccc12

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 1/20 0.41
MEN1 O00255 1/20 0.41
KMT2A Q03164 1/20 0.41
ACP3 P15309 1/20 0.37
CNR2 P34972 2/20 0.37
CYP2C9 P11712 3/20 0.37
HDAC3 O15379 1/20 0.37
HDAC1 Q13547 1/20 0.37
HDAC6 Q9UBN7 1/20 0.37
SLC6A4 P31645 1/20 0.37
ALDH1A1 P00352 1/20 0.36
CYP2C19 P33261 2/20 0.35
HPGD P15428 1/20 0.35
HTT P42858 1/20 0.35
TRPV1 Q8NER1 1/20 0.34
KIF11 P52732 1/20 0.34
AR P10275 1/20 0.34
CTSA P10619 1/20 0.34
NPY1R P25929 1/20 0.33
NPY5R Q15761 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4659937 1.00 KDM4E (0.41) KDM4EMEN1KMT2AACP3CNR2
SCHEMBL4663676 0.88 ALDH1A1 (0.43) ACP3CYP2C9ALDH1A1CYP2C19HPGD
SCHEMBL4660045 0.84 SMN1; SMN2 (0.40) KDM4EMEN1KMT2ACYP2C9HDAC3
SCHEMBL4661384 0.84 SLC6A4 (0.38) KDM4EMEN1KMT2ACNR2CYP2C9
SCHEMBL4661400 0.82 ALDH1A1 (0.39) KDM4EMEN1KMT2ACYP2C9ALDH1A1
SCHEMBL4661588 0.81 ALDH1A1 (0.36) MEN1KMT2AACP3CYP2C9ALDH1A1
SCHEMBL4661582 0.81 ALDH1A1 (0.39) MEN1KMT2ACYP2C9ALDH1A1CYP2C19
SCHEMBL4660174 0.81 ALOX5 (0.39) ACP3CYP2C9SLC6A4ALDH1A1CYP2C19
SCHEMBL4660208 0.80 CYP2C9 (0.45) MEN1KMT2AACP3CYP2C9HDAC6
SCHEMBL15949011 0.79 ACP3 (0.41) MEN1KMT2AACP3CNR2ALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US claimed
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use WYETH 2005-01-06 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20050004164-A1 2-Cyanopropanoic acid amide and ester derivatives and methods of their use HCAR2, PCCA, MCCC2 KDM4E 2836/4885MEN1 2575/4885KMT2A 2809/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.